Diabetes in Deutschland: Aktuelle Zahlen und Prävention — Diabetes prevention Germany statistics

TL;DR

Diabetes remains one of Germany's most common chronic diseases. Recent national and international data place the number of people with diagnosed type 2 diabetes in the multiple millions (roughly 8–9 million documented cases), with many more at high risk (prediabetes) or undiagnosed. Preventing new cases requires combined strategies: population policies (healthy food environments, active cities), robust primary‑care screening and referral, and accessible, evidence‑based lifestyle programs that support weight loss, improved diet and increased physical activity. Germany's public health institutions (Robert Koch Institute, Deutsche Diabetes Gesellschaft, BfR, DGIM and partners) provide surveillance, guidance and program models — but implementation at scale is the ongoing challenge. ([dzd-ev.de](https://www.dzd-ev.de/das-dzd/ueber-uns/zahlen-und-fakten?utm_source=openai))

Introduction

Diabetes mellitus — particularly type 2 diabetes — is a major public‑health problem in Germany, with wide implications for individuals, families and the health‑care system. This article summarizes the most recent, Germany‑specific numbers, explains who is most affected, clarifies diagnostic thresholds using mg/dL units, and lays out practical prevention strategies for policy makers, clinicians and individuals living in Germany.

Current Numbers: Prevalence, Incidence, Mortality

National surveillance and specialist reports show diabetes affects millions in Germany. Recent disease overviews and the annual German Health Report on Diabetes indicate that the documented population with diabetes—predominantly type 2—reaches roughly 8–9 million people in recent years. These counts come from clinical databases, health insurance records and national surveillance syntheses. ([dzd-ev.de](https://www.dzd-ev.de/das-dzd/ueber-uns/zahlen-und-fakten?utm_source=openai))

International estimates (IDF Diabetes Atlas) also place Germany among high‑burden European countries in absolute numbers, and project further increases if risk factors such as obesity and sedentariness are not curtailed. These numbers reflect both demographic ageing and lifestyle trends. ([diabetesatlas.org](https://diabetesatlas.org/media/uploads/sites/3/2025/04/IDF_Atlas_11th_Edition_2025-1.pdf?utm_source=openai))

Mortality and hospitalisation data show diabetes contributes substantially to cardiovascular disease, chronic kidney disease and limb complications. National statistics offices (Destatis) and clinical registries routinely include diabetes as a contributing or underlying cause in cause‑of‑death and hospital case reports. ([destatis.de](https://www.destatis.de/EN/Press/2024/01/PE24_011_126.html?utm_source=openai))

Who is Affected — Risk Groups and Social Factors

Key risk factors in Germany mirror global drivers: age (prevalence increases strongly with age), overweight/obesity, low physical activity, and diets high in ultra‑processed foods and sugary beverages. Socioeconomic inequalities mean that people with lower education and income have higher rates of diabetes and risk factors. Migrant background is also associated with elevated prevalence in some groups. ([rki.de](https://www.rki.de/DE/Themen/Nichtuebertragbare-Krankheiten/Koerperliche-Gesundheit/Adipositas-und-Uebergewicht/adipositas-und-uebergewicht-node.html?utm_source=openai))

Adiposity is especially important: public health analyses note that overweight and obesity prevalence in adults remains high in Germany and is a principal modifiable driver of type 2 diabetes risk. Germany's Federal Institute for Risk Assessment (BfR) and other public health bodies underline the connection between excess caloric intake, processed foods and metabolic risk. ([bfr.bund.de](https://www.bfr.bund.de/lebensmittelsicherheit/gesundheitliche-bewertung-von-ernaehrungsrisiken/ernaehrungsbedingte-erkrankungen/adipositas/?utm_source=openai))

Diagnosis and Blood‑glucose Thresholds (mg/dL)

For clinicians and people tracking their glucose, common diagnostic thresholds (reported here in mg/dL) are:

• Normal fasting plasma glucose: <100 mg/dL (some older or WHO criteria use <110 mg/dL). ([leitlinien.de](https://www.leitlinien.de/themen/diabetes/version-3/anhang?utm_source=openai))
• Prediabetes / impaired fasting glucose (IFG): 100–125 mg/dL (ADA definition) or 110–125 mg/dL in some older WHO/European cut‑offs. Individuals in this range have elevated short‑ and long‑term risk of progression. ([diabetesjournals.org](https://diabetesjournals.org/care/article/47/Supplement_1/S20/153954/2-Diagnosis-and-Classification-of-Diabetes?utm_source=openai))
• Diabetes (fasting): ≥126 mg/dL on venous plasma sampling (or a 2‑hour OGTT ≥200 mg/dL; a random plasma glucose ≥200 mg/dL with symptoms also diagnostic). HbA1c ≥6.5% is also used as a diagnostic criterion. Repeat testing is recommended unless clear symptomatic hyperglycaemia is present. ([diabetesjournals.org](https://diabetesjournals.org/care/article/46/Supplement_1/S19/148056/2-Classification-and-Diagnosis-of-Diabetes?utm_source=openai))

Using mg/dL in Germany is common in international clinical literature; German lab reports sometimes use mmol/L — when converting remember that 1 mmol/L ≈ 18 mg/dL.

Germany's Health System & Surveillance

Surveillance and clinical guidance are well‑established in Germany. The Robert Koch Institute (RKI) maintains diabetes surveillance and national health surveys (DEGS, GEDA) that feed estimates of prevalence, complications and comorbidities. Specialist societies—Deutsche Diabetes Gesellschaft (DDG) and the patient organisation diabetesDE—produce the annual Deutscher Gesundheitsbericht Diabetes, synthesising evidence for policy and practice. ([rki.de](https://www.rki.de/EN/Topics/Noncommunicable-diseases/Physical-health/Diabetes-Mellitus/diabetes-mellitus-node.html?utm_source=openai))

At the clinical level, Germany offers Disease Management Programs (DMPs) for type 2 diabetes, broad statutory health‑insurance coverage, and established guidelines (S3/National Care Guidelines) that align prevention, screening and treatment pathways. Professional societies such as DGIM (internal medicine) actively advocate for measurable, evidence‑based prevention initiatives. ([ddg.info](https://www.ddg.info/fileadmin/user_upload/05_Behandlung/01_Leitlinien/Evidenzbasierte_Leitlinien/2023/nvl-001l_S3_Typ-2-Diabetes_2023-05-2.pdf_151123.pdf?utm_source=openai))

Population‑level Prevention: Policy & Environment

Large reductions in new diabetes cases require changes beyond clinical care. Population measures include:

• Creating healthier food environments — reducing availability and marketing of high‑calorie, nutrient‑poor ultra‑processed foods and sugary drinks. German nutritional authorities (DGE) and the BfR have highlighted the links between ultra‑processed food consumption and cardiometabolic risk. ([dge.de](https://www.dge.de/presse/meldungen/2023/wie-wirken-stark-verarbeitete-lebensmittel-auf-die-gesundheit/?utm_source=openai))
• Urban planning and active‑transport policies to increase daily physical activity (walkable neighbourhoods, cycling infrastructure), which reduce obesity and diabetes risk. DGIM and other medical societies have recently called for prevention strategies that combine individual responsibility with environmental measures. ([dgim.de](https://www.dgim.de/presse/pressemitteilungen/24072026-praevention-braucht-evidenz-und-messbare-ziele?utm_source=openai))
• Workplace and school interventions that improve nutrition and physical activity opportunities, and public information campaigns to raise awareness of prediabetes and early detection. The National Prevention Strategy in Germany and related initiatives create structures for such measures. ([ddg.info](https://www.ddg.info/politik/veroeffentlichungen/gesundheitsbericht?utm_source=openai))

Evidence from other high‑income settings (DPP‑style trials) shows that structured lifestyle programs delivered at scale can cut progression to type 2 diabetes by about 40–60% in people with prediabetes. Translating this evidence into equitable access across Germany is a priority for public health agencies. ([diabetesatlas.org](https://diabetesatlas.org/media/uploads/sites/3/2025/04/IDF_Atlas_11th_Edition_2025-1.pdf?utm_source=openai))

Individual‑level Prevention: Practical Steps for Residents of Germany

What can individuals do now? Practical, evidence‑based measures include:

1. Know your numbers: ask your GP for fasting plasma glucose, HbA1c and lipid profile if you have risk factors (age >40, overweight, family history, migration background with higher risk). Early detection enables lifestyle referral. ([dzd-ev.de](https://www.dzd-ev.de/diabetes/diabetesdiagnose?utm_source=openai))
2. Target modest, sustainable weight loss: even 5–7% bodyweight loss lowers diabetes risk substantially for people with prediabetes. Use structured programmes (see below) rather than fad diets for durable results. ([ddg.info](https://www.ddg.info/politik/veroeffentlichungen/gesundheitsbericht?utm_source=openai))
3. Adopt Mediterranean‑style or balanced whole‑food diets, reduce sugary drinks and ultra‑processed foods, and prioritise vegetables, legumes, whole grains, nuts and lean protein. German nutrition guidance (DGE) provides practical nutrient and meal guidance. ([dge.de](https://www.dge.de/gesunde-ernaehrung/diaetetik-und-kostformen/uebergewicht-und-adipositas/?utm_source=openai))
4. Increase physical activity: aim for ≥150 minutes/week of moderate aerobic activity plus two sessions of strength training. Active transport (walking, cycling) integrates movement into daily life. ([dgim.de](https://www.dgim.de/presse/pressemitteilungen/24072026-praevention-braucht-evidenz-und-messbare-ziele?utm_source=openai))
5. Quit smoking and limit harmful alcohol intake — both increase cardiometabolic risk. Seek help from local prevention services and statutory health insurance offerings (Krankenkasse). ([gesund.bund.de](https://gesund.bund.de/uebergewicht-adipositas?utm_source=openai))
6. Use local support: diabetesDE, DDG and many Krankenkassen offer courses, digital programmes and coaching. Ask your GP about referrals to certified 'Gesundheitskurse' or DMP entry. ([diabetesde.org](https://www.diabetesde.org/gesundheitsberichte?utm_source=openai))

Evidence‑based Prevention Programs in Germany

Germany offers several program models that translate international evidence into local practice: structured lifestyle courses reimbursed by statutory insurers, digital prevention offers, and regional pilot projects linked to public‑health departments. The DDG and diabetesDE annual health reports highlight scalable models and recommend improving access so high‑risk people receive timely lifestyle interventions. ([ddg.info](https://www.ddg.info/politik/veroeffentlichungen/gesundheitsbericht?utm_source=openai))

Clinical guidelines (S3) and national programs encourage primary‑care screening for people at elevated risk and timely referral to lifestyle programmes. The successful expansion of such services depends on reimbursement, workforce training (dietitians, exercise therapists), and data systems for follow‑up. ([ddg.info](https://www.ddg.info/fileadmin/user_upload/05_Behandlung/01_Leitlinien/Evidenzbasierte_Leitlinien/2023/nvl-001l_S3_Typ-2-Diabetes_2023-05-2.pdf_151123.pdf?utm_source=openai))

Key Challenges & Opportunities

Challenges:

• Social inequalities: lower socioeconomic groups carry a disproportionate diabetes burden; equitable access is essential. ([rki.de](https://www.rki.de/DE/Themen/Nichtuebertragbare-Krankheiten/Koerperliche-Gesundheit/Adipositas-und-Uebergewicht/adipositas-und-uebergewicht-node.html?utm_source=openai))
• Behavioural change at scale: it is hard to translate short‑term trial results into long‑term, population‑level risk reduction without sustained support and environmental changes. ([ddg.info](https://www.ddg.info/politik/veroeffentlichungen/gesundheitsbericht?utm_source=openai))
• Coordination across sectors (health, transport, urban planning, food policy) is required but complex. DGIM and other professional bodies are calling for measurable prevention targets in federal strategy. ([dgim.de](https://www.dgim.de/presse/pressemitteilungen/24072026-praevention-braucht-evidenz-und-messbare-ziele?utm_source=openai))

Opportunities:

• Germany's robust surveillance (RKI) and strong specialist societies (DDG, DZD, DGIM) create a foundation for data‑driven policy. Strengthening reimbursement for proven prevention programs and integrating digital coaching can support scale‑up. ([rki.de](https://www.rki.de/EN/Topics/Noncommunicable-diseases/Physical-health/Diabetes-Mellitus/diabetes-mellitus-node.html?utm_source=openai))
• Targeted interventions for high‑risk groups (workplace, migrants, lower‑income communities) could yield disproportionate gains in reducing new cases. ([bzfe.de](https://www.bzfe.de/presse/pressemeldungen-archiv/uebergewicht-und-adipositas-in-deutschland?utm_source=openai))

Scientific References (selected Germany & international sources)

1. Robert Koch Institute (RKI) — Diabetes mellitus / National Diabetes Surveillance. ([rki.de](https://www.rki.de/EN/Topics/Noncommunicable-diseases/Physical-health/Diabetes-Mellitus/diabetes-mellitus-node.html?utm_source=openai))
2. Deutsche Diabetes Gesellschaft (DDG) — Deutscher Gesundheitsbericht Diabetes (annual report). ([ddg.info](https://www.ddg.info/politik/veroeffentlichungen/gesundheitsbericht?utm_source=openai))
3. diabetesDE — Deutsche Diabetes‑Hilfe: health reports and patient resources. ([diabetesde.org](https://www.diabetesde.org/gesundheitsberichte?utm_source=openai))
4. International Diabetes Federation (IDF) — Diabetes Atlas (2025 edition). ([diabetesatlas.org](https://diabetesatlas.org/media/uploads/sites/3/2025/04/IDF_Atlas_11th_Edition_2025-1.pdf?utm_source=openai))
5. Deutsches Zentrum für Diabetesforschung (DZD) — Facts and figures. ([dzd-ev.de](https://www.dzd-ev.de/das-dzd/ueber-uns/zahlen-und-fakten?utm_source=openai))
6. DGIM — statements on prevention and the need for measurable goals (2026). ([dgim.de](https://www.dgim.de/presse/pressemitteilungen/24072026-praevention-braucht-evidenz-und-messbare-ziele?utm_source=openai))
7. Federal Statistical Office (Destatis) — mortality and hospital statistics in Germany. ([destatis.de](https://www.destatis.de/EN/Press/2024/01/PE24_011_126.html?utm_source=openai))
8. Bundesinstitut für Risikobewertung (BfR) — food, sugar and obesity comments. ([bfr.bund.de](https://www.bfr.bund.de/presseinformation/diabetiker-brauchen-keine-speziellen-lebensmittel/?utm_source=openai))
9. Deutsche Gesellschaft für Ernährung (DGE) — nutrition guidance and reviews on ultra‑processed food. ([dge.de](https://www.dge.de/gesunde-ernaehrung/diaetetik-und-kostformen/uebergewicht-und-adipositas/?utm_source=openai))
10. American Diabetes Association / Diabetes Care — diagnostic criteria and standards of care (used for mg/dL thresholds). ([diabetesjournals.org](https://diabetesjournals.org/care/article/46/Supplement_1/S19/148056/2-Classification-and-Diagnosis-of-Diabetes?utm_source=openai))

FAQ (Frequently Asked Questions)

1. How many people in Germany have diabetes today?

Recent Germany‑focused syntheses estimate roughly 8–9 million documented cases of type 2 diabetes; annual national reports and the DZD provide the most up‑to‑date figures. Estimates differ slightly depending on data sources and whether undiagnosed cases are included. ([dzd-ev.de](https://www.dzd-ev.de/das-dzd/ueber-uns/zahlen-und-fakten?utm_source=openai))

2. What blood glucose level indicates prediabetes or diabetes (in mg/dL)?

Prediabetes (impaired fasting glucose) is commonly defined as fasting plasma glucose 100–125 mg/dL; diabetes is usually diagnosed at fasting plasma glucose ≥126 mg/dL or a 2‑hour OGTT ≥200 mg/dL, or HbA1c ≥6.5%. Repeat testing is recommended for confirmation. ([diabetesjournals.org](https://diabetesjournals.org/care/article/46/Supplement_1/S19/148056/2-Classification-and-Diagnosis-of-Diabetes?utm_source=openai))

3. Can lifestyle changes really prevent diabetes?

Yes. High‑quality trials (and translations of these trials into real‑world programs) show structured lifestyle interventions—weight loss through diet, increased physical activity, and behavioural support—can reduce progression from prediabetes to type 2 diabetes by roughly 40–60% over several years. Germany's health reports recommend scaling these programs. ([diabetesatlas.org](https://diabetesatlas.org/media/uploads/sites/3/2025/04/IDF_Atlas_11th_Edition_2025-1.pdf?utm_source=openai))

4. Are there national programs in Germany I can join?

Many statutory health insurers (Krankenkassen) reimburse certified prevention courses and digital programmes. Your GP can advise about local offerings, and organisations like diabetesDE and DDG list resources and programmes in Germany. DMPs exist for people already diagnosed with diabetes. ([diabetesde.org](https://www.diabetesde.org/gesundheitsberichte?utm_source=openai))

5. What role do food policy and sugar play in prevention?

Reducing consumption of sugar‑sweetened beverages and ultra‑processed foods is recommended as part of diabetes prevention. BfR and DGE analyses emphasise that changing food environments and product composition supports healthier choices at scale. ([bfr.bund.de](https://www.bfr.bund.de/lebensmittel-und-futtermittelsicherheit/bewertung-der-stofflichen-risiken-von-lebensmitteln/bewertung-von-lebensmittelinhaltsstoffen/bewertung-von-kohlenhydraten-fetten-proteinen-in-lebensmitteln/?utm_source=openai))

6. Should I get screened if I feel fine?

If you have risk factors (age >40, overweight, family history, previous gestational diabetes, high blood pressure), ask your GP about screening via fasting glucose or HbA1c. Early detection of prediabetes enables referral to prevention programmes. ([dzd-ev.de](https://www.dzd-ev.de/diabetes/diabetesdiagnose?utm_source=openai))

7. How does Germany compare internationally?

In absolute numbers Germany is among the European countries with high total case counts (driven partly by population size and ageing). Age‑standardised prevalence varies across countries; international comparisons are available via the IDF Diabetes Atlas. ([diabetesatlas.org](https://diabetesatlas.org/media/uploads/sites/3/2025/04/IDF_Atlas_11th_Edition_2025-1.pdf?utm_source=openai))

Medical Disclaimer

This article is for information only and does not replace personalised medical advice. For diagnosis, treatment or screening, consult your GP or a specialist (Endocrinologist/Diabetologist). Clinical thresholds and recommendations cited here are based on published guidelines and sources; individual clinical decisions should be made with a health professional. ([diabetesjournals.org](https://diabetesjournals.org/care/article/46/Supplement_1/S19/148056/2-Classification-and-Diagnosis-of-Diabetes?utm_source=openai))

Related articles (internal)

• Do weight‑loss programs work? Lessons relevant to diabetes prevention
• Intermittent fasting and blood sugar control
• Health business models and prevention program delivery
• Dietary fiber and metabolic health
• How to improve insulin sensitivity naturally
• Natural diabetes management tips
• Gut health and metabolic disease links
• Blood sugar management and insulin resistance — practical tips